TCL Archive Obama Plan Would Double Cancer Funding, Increase Clinical Trial Enrollment To 10%. November 7, 2008
TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study December 26, 2014